Moderna Therapeutics, which last week set terms for its upcoming IPO, has dropped an underwriter because it made "unauthorized communications" about the offering, per an SEC filing. Of the underwriters listed in the original filing, the only one missing in the updated version is London-based investment banker Bryan Garnier. Moderna expects to raise up to $600 million in its public offering.